Search results
New study involving nearly 185,000 patients recommends strengthening immunity against COVID-19 in...
Medical Xpress· 6 days agoResearchers from the Institut d'Investigació en Atenció Primària Jordi Gol (IDIAPJGol) and the Barcelona Institute for Global Health (ISGlobal) have led a study on the effectiveness of vaccines ...
They recommend strengthening immunity against Covid-19 in people with cancer
Hardwood Paroxysm· 6 days agoResearchers from the Jordi Gol Institute for Primary Care Research (IDIAPJGol) and the Institute for...
Xencor (XNCR) – Research Analysts’ Weekly Ratings Updates
ETF DAILY NEWS· 11 hours ago6/14/2024 – Xencor had its price target lowered by analysts at Raymond James from $58.00 to $40.00. 6/14/2024 – Xencor had its price target lowered by analysts at BMO Capital Markets from $34.00 ...
Pushing Medical Boundaries in Fight Against COVID-19
New Jersey Business Magazine· 2 days agoThe state’s ongoing efforts to advance medical technology and healthcare delivery hold new relevance in the treatment of diseases such as COVID-19....
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market...
Morningstar· 5 days agoFN Media Group News Commentary - The National Cancer Institute’s (NCI) funding of research projects is predicted to empower the Pancreatic Cancer Market to grow. Unlike traditional therapeutic ...
A study conducted by IDIAPJGol and ISGlobal recommends enhancing immunity against COVID-19 in cancer...
Hardwood Paroxysm· 5 days agoResearchers from the Jordi Gol Institute for Primary Care Research (IDIAPJGol) and the Barcelona...
Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of “Buy” by Analysts
ETF DAILY NEWS· 3 days agoShares of Xencor, Inc. (NASDAQ:XNCR – Get Free Report) have received an average recommendation of “Buy” from the eight ratings firms that are presently covering the stock, MarketBeat.com reports ...